Sara Bonstein, Chief Financial Officer at INSMED Inc (INSM), sold 115,432 shares at $87.12 ($10.3M) on 2025-06-10, disclosed to the SEC on 2025-06-12.
Scheduled sale ($10.3M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.12 | 7,277 | $634K | 6.2% |
| 2 | $87.12 | 7,277 | $634K | 6.2% |
| 3 | $88.29 | 7,310 | $645K | 6.3% |
| 4 | $88.29 | 7,310 | $645K | 6.3% |
| 5 | $88.99 | 20,926 | $1.9M | 18.1% |
| 6 | $88.99 | 20,926 |
| $1.9M |
| 18.1% |
| 7 | $89.85 | 15,825 | $1.4M | 13.8% |
| 8 | $89.85 | 15,825 | $1.4M | 13.8% |
| 9 | $90.93 | 6,328 | $575K | 5.6% |
| 10 | $90.93 | 6,328 | $575K | 5.6% |
| 11 | $91.66 | 100 | $9K | 0.1% |
| Total | $89.12 avg | 115,432 | $10.3M | 100% |
| Filing → |
| INSM | SELL | 2026-02-04 | $117K | — | Filing → |
| INSM | SELL | 2026-01-08 | $809K | — | Filing → |
| INSM | SELL | 2025-07-23 | $12.0M | — | Filing → |